Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadratus Lumborum Block for Chronic Neuropathic Pain After Laparoscopic Donor Nephrectomy
NCT07037992Active, not recruiting
- Sponsor
- Universitas Indonesia
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in chronic neuropathic pain (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Neuropathic Pain in 4 Questionnaire at 3 months, Behavioral Pain Interference at 3 months and 9 more. Started Nov 2025; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT07037992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07037992.